AI News NQ Analysis

Renewal Launch of Quasi-Drug "Iskra Phage Skin Balance Medicated Milky Lotion" for Acne Prevention

NQ Score 0/100
N1 Content Completeness 3

Key facts

  • Renewal Launch of Quasi-Drug "Iskra Phage Skin Balance Medicated Milky Lotion" for Acne Prevention
  • Iskra Industry Co., Ltd. announced the renewal launch of "Iskra Phage Skin Balance Medicated Milky Lotion," a quasi-drug designed to prevent acne.
  • Source: PR TIMES
  • Date: Mon Apr 13 2026 15:43:08 GMT+0900 (Japan Standard Time)

Direct answer

Iskra Industry Co., Ltd. announced the renewal launch of "Iskra Phage Skin Balance Medicated Milky Lotion," a quasi-drug designed to prevent acne.

Citation
Renewal Launch of Quasi-Drug "Iskra Phage Skin Balance Medicated Milky Lotion" for Acne Prevention (Mon Apr 13 2026 15:43:08 GMT+0900 (Japan Standard Time)), PR TIMES
Source
PR TIMES
Date
Mon Apr 13 2026 15:43:08 GMT+0900 (Japan Standard Time)

AI Summary (NQ-processed)

Iskra Industry Co., Ltd. announced the renewal launch of "Iskra Phage Skin Balance Medicated Milky Lotion," a quasi-drug designed to prevent acne.

AI Analysis

Frequently Asked Questions

Q: What is the renewal launch product mentioned in the title of the article?
A: The renewal launch product is a quasi-drug named "Iskra Phage Skin Balance Medicated Milky Lotion" for acne prevention.
Q: Where is the head office location of the company mentioned in the article?
A: The head office location of the company is 2-10-6 Nihonbashi, Chuo-ku, Tokyo 103-0027.
Q: When was the company mentioned in the article established?
A: The company was established in March 1960 according to the provided text.
Q: What is the total amount of capital of the company mentioned in the article?
A: The capital of the company is 100 million yen as stated in the text.
Q: Who is the president and representative director of the company?
A: The president and representative director of the company is Zhiqing Chen.